About Curebase
Curebase is a company based in San Francisco (United States) founded in 2017. Curebase has raised $59.01 million across 4 funding rounds from investors including Gilead, Industry Ventures and Acrew Capital. Curebase offers products and services including ePRO/eCOA, eConsent, Unified Participant Experience, and EDC. Curebase operates in a competitive market with competitors including L7 Informatics, MDClone, Clinical Research IO, THREAD and VivoSense, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Curebase, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$59.01 M (USD)
in 4 rounds
-
Latest Funding Round
$40 M (USD), Series B
May 05, 2022
-
Investors
Gilead
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curebase
Curebase offers a comprehensive portfolio of products and services, including ePRO/eCOA, eConsent, Unified Participant Experience, and EDC.
Tools for electronic patient-reported outcomes in clinical trials.
Platform for paperless consent in multi-device clinical studies.
Integrated mobile system for study prescreening and data submission.
Unified platform for hybrid study data management and monitoring.
People of Curebase
Unlock access to complete
Funding Insights of Curebase
Curebase has successfully raised a total of $59.01M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $40 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Curebase
Curebase has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Gilead, Industry Ventures and Acrew Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in private tech ecosystem are made by Industry Ventures.
|
Locked | Locked | Locked | |
|
Early-stage startups are funded by Acrew Capital venture firm.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on SaaS, mobile tech, AI, and multiple sectors
|
Locked | Locked | Locked |
Investor details for Curebase
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Curebase
Investment portfolio details for Curebase
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Curebase
Detailed financials for Curebase
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Curebase Comparisons
Peer comparison for Curebase
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Curebase
Curebase operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as L7 Informatics, MDClone, Clinical Research IO, THREAD and VivoSense, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Clinical trial workflow management software is provided for laboratories.
|
|
| Locked | Locked | Locked |
Provider of software that creates synthetic medical records for fictitious patients
|
|
| Locked | Locked | Locked |
Clinical trial management software is provided for research sites.
|
|
| Locked | Locked | Locked |
Provider of patient research studies software
|
|
| Locked | Locked | Locked |
Wearable sensor research analysis platform
|
Detailed competitors of Curebase
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Curebase
Complete news archive for Curebase
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curebase
Curebase was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Curebase is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Storm Stillman is the current CEO of Curebase.
Curebase is a funded company, having raised a total of $59.01M across 4 funding rounds to date.
Curebase was founded in 2017 in San Francisco, United States, within the clinical research sector. A platform is operated to facilitate patient enrollment and engagement for decentralized trials. Eligibility screening, enrollment processes, participant education, and consent management are streamlined. In-app guidance on protocols is delivered to users, alongside capabilities for document scanning and upload. Operations focus on enhancing trial conduction efficiency.
Curebase's top competitors include L7 Informatics, Sonrai Analytics and MDClone.
Curebase offers ePRO/eCOA, eConsent, Unified Participant Experience, and EDC.
Curebase has 10 investors. Key investors include Gilead, Industry Ventures, Acrew Capital, World Innovation Lab, and Positive Sum.